uniQure B.V.
September 24, 2025 - by Joey Ramson
$QURE is currently up over 250% after the company said its experimental gene therapy successfully treated Huntington’s disease. The disease is a neurological condition that slowly destroys brain cells, robbing patients of their ability to move and reason. But a high dose of $QURE AMT-130 slowed disease progression by 75% after three years.
